GGLCX
Price
$13.97
Change
-$0.16 (-1.13%)
Updated
Jul 31 closing price
Net Assets
6.34M
OSMNX
Price
$33.92
Change
-$0.41 (-1.19%)
Updated
Jul 31 closing price
Net Assets
2.39B
Interact to see
Advertisement

GGLCX vs OSMNX

GGLCX vs OSMNX Comparison Chart in %
View a ticker or compare two or three
VS
GGLCX vs. OSMNX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGLCX is a Buy and OSMNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSMNX has more cash in the bank: 2.39B vs. GGLCX (6.34M). GGLCX pays higher dividends than OSMNX: GGLCX (2.13) vs OSMNX (1.22). GGLCX was incepted earlier than OSMNX: GGLCX (25 years) vs OSMNX (25 years). GGLCX (4.40) is less costly to investors than OSMNX (1.68). OSMNX is a more actively managed with annual turnover of: 52.00 vs. GGLCX (13.00). GGLCX (1000) and OSMNX (1000) have matching initial minimum investment requirements. GGLCX annual gain was more profitable for investors over the last year : 17.81 vs. OSMNX (-10.62). GGLCX return over 5 years is better than : 1.20 vs. OSMNX (-39.77).
GGLCXOSMNXGGLCX / OSMNX
Total Expense Ratio0.911.6854%
Annual Report Gross Expense Ratio4.401.68262%
Fund Existence25 years25 years-
Gain YTD0.5045.9348%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets6.34M2.39B0%
Annual Yield % from dividends2.131.22174%
Returns for 1 year17.81-10.62-168%
Returns for 3 years31.50-11.21-281%
Returns for 5 years1.20-39.77-3%
Returns for 10 years-35.88-3.581,001%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAPEX3167.5943.94
+1.41%
Eaton Vance Tx-Mgd Growth 1.0
TVLAX12.630.05
+0.40%
Touchstone Value A
ETLNX16.860.06
+0.36%
Eventide Large Cap Focus N
RISIX13.34-0.03
-0.22%
RBC International Small Cap Equity I
JMEEX70.18-0.18
-0.26%
JPMorgan Mid Cap Equity R5